Loading ...

Safety of RG2077 in Patients With Multiple Sclerosis

(

)

ITN Protocol #:

ITN006AI

Branded Name:

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase I Study To Assess The Safety Of RG2077 (CTLA4-IgG4m) In Patients With Relapsing-Remitting Multiple Sclerosis

Study Personnel:

Protocol Chair

Samia Khoury, MD skhoury@rics.bwh.harvard.edu

Work:

617-525-5370

Admin Links

Shortcuts

ITN Documents

Links